Ipsen S.A.

ENXTPA:IPN Stock Report

Market Cap: €9.7b

Ipsen Dividends and Buybacks

Dividend criteria checks 4/6

Ipsen is a dividend paying company with a current yield of 1.21% that is well covered by earnings.

Key information

1.2%

Dividend yield

0.3%

Buyback Yield

Total Shareholder Yield1.6%
Future Dividend Yield1.2%
Dividend Growth4.9%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ratio26%

Recent dividend and buyback updates

Ipsen (EPA:IPN) Is Increasing Its Dividend To €1.40

May 16
Ipsen (EPA:IPN) Is Increasing Its Dividend To €1.40

Ipsen's (EPA:IPN) Upcoming Dividend Will Be Larger Than Last Year's

Apr 29
Ipsen's (EPA:IPN) Upcoming Dividend Will Be Larger Than Last Year's

Ipsen's (EPA:IPN) Dividend Will Be Increased To €1.40

Apr 14
Ipsen's (EPA:IPN) Dividend Will Be Increased To €1.40

Recent updates

Investors Interested In Ipsen S.A.'s (EPA:IPN) Earnings

Jul 13
Investors Interested In Ipsen S.A.'s (EPA:IPN) Earnings

Ipsen (EPA:IPN) Is Increasing Its Dividend To €1.40

May 16
Ipsen (EPA:IPN) Is Increasing Its Dividend To €1.40

Ipsen's (EPA:IPN) Upcoming Dividend Will Be Larger Than Last Year's

Apr 29
Ipsen's (EPA:IPN) Upcoming Dividend Will Be Larger Than Last Year's

Ipsen's (EPA:IPN) Dividend Will Be Increased To €1.40

Apr 14
Ipsen's (EPA:IPN) Dividend Will Be Increased To €1.40
User avatar

Cabometyx And Tovorafenib Approvals May Strengthen Oncology Portfolio In 2025

Expansion of Onivyde and new product approvals could significantly increase revenue and strengthen market positions in key medical segments.

Ipsen's (EPA:IPN) Soft Earnings Don't Show The Whole Picture

Feb 21
Ipsen's (EPA:IPN) Soft Earnings Don't Show The Whole Picture

Is Ipsen S.A. (EPA:IPN) Trading At A 44% Discount?

Feb 14
Is Ipsen S.A. (EPA:IPN) Trading At A 44% Discount?

Pinning Down Ipsen S.A.'s (EPA:IPN) P/E Is Difficult Right Now

Jan 20
Pinning Down Ipsen S.A.'s (EPA:IPN) P/E Is Difficult Right Now

Is Ipsen (EPA:IPN) Using Too Much Debt?

Dec 24
Is Ipsen (EPA:IPN) Using Too Much Debt?

What Ipsen S.A.'s (EPA:IPN) P/E Is Not Telling You

Sep 30
What Ipsen S.A.'s (EPA:IPN) P/E Is Not Telling You

These 4 Measures Indicate That Ipsen (EPA:IPN) Is Using Debt Reasonably Well

Sep 08
These 4 Measures Indicate That Ipsen (EPA:IPN) Is Using Debt Reasonably Well

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: IPN's dividends per share have been stable in the past 10 years.

Growing Dividend: IPN's dividend payments have increased over the past 10 years.


Dividend Yield vs Market

Ipsen Dividend Yield vs Market
How does IPN dividend yield compare to the market?
SegmentDividend Yield
Company (IPN)1.2%
Market Bottom 25% (FR)2.1%
Market Top 25% (FR)5.4%
Industry Average (Pharmaceuticals)4.2%
Analyst forecast (IPN) (up to 3 years)1.2%

Notable Dividend: IPN's dividend (1.21%) isn’t notable compared to the bottom 25% of dividend payers in the French market (2.06%).

High Dividend: IPN's dividend (1.21%) is low compared to the top 25% of dividend payers in the French market (5.38%).


Earnings Payout to Shareholders

Earnings Coverage: With its reasonably low payout ratio (25.8%), IPN's dividend payments are well covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its low cash payout ratio (19.4%), IPN's dividend payments are well covered by cash flows.


Discover strong dividend paying companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/08/29 17:36
End of Day Share Price 2025/08/29 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Ipsen S.A. is covered by 33 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Charles PitmanBarclays
Richard SilverBarclays
Hae Won NaBerenberg